NCT05919407 2023-06-26
IMPACT-MG
Leiden University Medical Center
Phase 3 Unknown
Clinical Trials
3 trialsNCT05332210 2023-03-08
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 3 Unknown
NCT05332587 2022-05-02
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown